Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-046809
Filing Date
2021-07-15
Accepted
2021-07-15 17:53:20
Documents
1
Period of Report
2021-07-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3461
  Complete submission text file 0001209191-21-046809.txt   5058
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Issuer) CIK: 0001595893 (see all company filings)

EIN.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CENTREXION THERAPEUTICS CORPORATION 200 STATE STREET BOSTON MA 02109
Business Address
Partridge Andrew John (Reporting) CIK: 0001758838 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38871 | Film No.: 211093593